safety group

BIOLOGICAL2 trials

Sponsors

Sinovac (Dalian) Vaccine Technology Co., Ltd., Centre de Recherches Medicales de Lambarene

Conditions

MalariaMumps

Phase 1

Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adults

Active, not recruitingPACTR201908520097051

Centre de Recherches Medicales de LambareneMalaria

Start: 2019-05-21Target: 49Updated: 2026-08-03

Unknown Phase

Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old

CompletedNCT05145166

Sinovac (Dalian) Vaccine Technology Co., Ltd.Mumps

Start: 2020-10-06End: 2021-03-25Updated: 2021-12-06

Related Papers

Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial.

2023-10-136 citations